The store will not work correctly when cookies are disabled.
N-(1-benzylpiperidin-4-yl)isobutyramide
ID: ALA4089518
Cas Number: 312924-69-9
PubChem CID: 1530639
Max Phase: Preclinical
Molecular Formula: C16H24N2O
Molecular Weight: 260.38
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)C(=O)NC1CCN(Cc2ccccc2)CC1
Standard InChI: InChI=1S/C16H24N2O/c1-13(2)16(19)17-15-8-10-18(11-9-15)12-14-6-4-3-5-7-14/h3-7,13,15H,8-12H2,1-2H3,(H,17,19)
Standard InChI Key: JVFAKLWNQPCTQG-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 20 0 0 0 0 0 0 0 0999 V2000
23.1876 -6.7568 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8979 -6.3455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6112 -6.7514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
23.8948 -5.5242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.3174 -6.3402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0294 -6.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7376 -6.3410 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7387 -5.5193 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
26.0255 -5.1071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3111 -5.5207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4505 -5.1066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1624 -5.5194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1573 -6.3405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8683 -6.7490 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5811 -6.3404 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5785 -5.5148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8669 -5.1059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4742 -6.3508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.1906 -7.5781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 2 0
3 5 1 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
8 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
1 18 1 0
1 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 260.38 | Molecular Weight (Monoisotopic): 260.1889 | AlogP: 2.42 | #Rotatable Bonds: 4 |
Polar Surface Area: 32.34 | Molecular Species: BASE | HBA: 2 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 8.54 | CX LogP: 2.19 | CX LogD: 1.02 |
Aromatic Rings: 1 | Heavy Atoms: 19 | QED Weighted: 0.90 | Np Likeness Score: -1.30 |
References
1. Jørgensen L, Al-Khawaja A, Kickinger S, Vogensen SB, Skovgaard-Petersen J, Rosenthal E, Borkar N, Löffler R, Madsen KK, Bräuner-Osborne H, Schousboe A, Ecker GF, Wellendorph P, Clausen RP.. (2017) Structure-Activity Relationship, Pharmacological Characterization, and Molecular Modeling of Noncompetitive Inhibitors of the Betaine/γ-Aminobutyric Acid Transporter 1 (BGT1)., 60 (21): [PMID:28991462] [10.1021/acs.jmedchem.7b00924] |